Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado, a Body Corporate”

252 pharma patents match "The Regents of the University of Colorado, a Body Corporate" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 252
Index total 30,257
Page 8 / 11

Quick answer

This filtered view shows 252 pharmaceutical patents matching "The Regents of the University of Colorado, a Body Corporate" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

252 results for “The Regents of the University of Colorado, a Body Corporate” · 30,257 patents in full index Clear search

  1. US 9518090

    Compositions and methods for treating hepatitis B

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  2. US 9512481

    Polymorphisms in the PDE3A gene

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

  3. US 9499606

    Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  4. US 9486509

    Compositions and methods for preparing a subject for organ or non-organ implantation

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  5. US 9480673

    Composition and method for treating neurodegenerative disease

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  6. US 9474784

    Therapeutic applications of SMAD7

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  7. US 9457070

    Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  8. US 9456997

    Selective inhibition of β1-adrenergic receptors for the treatment of pediatric heart failure

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  9. US 9447406

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  10. US 9422352

    PTD-SMAD7 therapeutics

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  11. US 9422340

    Macrocyclic compounds useful as inhibitors of histone deacetylases

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  12. US 9409880

    Modulators of TLR3/dsRNA complex and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  13. US 9402881

    Tissue regeneration and wound treatment methods with platelet derived compositions

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  14. US 9387245

    Methods and compositions for the inhibition of fructokinase

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  15. US 9372186

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  16. US 9352015

    Antimicrobial peptides

    The Regents of the University of Colorado, a Body Corporate · Granted May 31, 2016 · Expires May 26, 2036

    granted

  17. US 9345726

    CD117+ cells and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted May 24, 2016 · Expires May 19, 2036

    granted

  18. US 9346865

    Antimicrobial peptides and methods of use

    The Regents of the University of Colorado, a Body Corporate · Granted May 24, 2016 · Expires May 19, 2036

    granted

  19. US 9295674

    Metalloporphyrin neurological treatments

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  20. US 9284546

    Human cystathionine beta-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted

  21. US 9259488

    Anti-C3d antibody conjugates and methods of detecting complement activation

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  22. US 9243239

    Purification of cystathionine beta-synthase

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  23. US 9212212

    Targeting complement factor H for treatment of diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  24. US 9180196

    Photodegradable groups for tunable polymeric materials

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.